Researchers have identified a new cellular pathway that limits the growth and spread of brain tumors by controlling the recycling of cell surface receptor proteins. The study, which is published in the Journal of Cell Biology (JCB), suggests that the pathway, which involves a protein called Rab35, is defective in many patients with glioblastoma and that restoring Rab35's activity could be a new therapeutic strategy for this deadly form of brain cancer.
Glioblastoma is the most aggressive type of brain cancer, and because it is largely untreatable, the average patient dies within 14 months of diagnosis. Like in other cancers, the proliferation and spread of glioblastoma cells depends on various receptor proteins on the outside of the cell. The levels of these receptor proteins are controlled by cellular transport pathways that internalize the receptors and then either degrade them or return them to the cell surface.
In normal, healthy cells, these transport pathways are regulated by a class of protein known as small GTPases. "We previously demonstrated that the levels of a small GTPase called Rab35 are decreased in human glioblastomas," says the senior author. "We thus sought to investigate the role of Rab35 in the progression of glioblastoma."
The authors found that reducing the levels of Rab35 increased the growth and spread of brain tumors in mice, thereby shortening the animals' life span. In contrast, elevating Rab35 levels reduced tumor growth and prolonged the animals' survival.
The researchers discovered that Rab35 is activated by a pathway involving another small GTPase called Arf5. Together, Arf5 and Rab35 appear to control the transport of various cell surface receptors, thereby restricting the ability of cells to migrate and invade through tissues, and limiting the ability of brain tumor-initiating cells to replicate.
One of the cell surface receptors controlled by this pathway is the signaling protein epidermal growth factor receptor (EGFR). In glioblastoma cells lacking Rab35, EGFR is increasingly recycled to the cell surface instead of being degraded, enhancing the receptor's signaling activity. Inhibiting EGFR with the cancer drug erlotinib reduced the production of a protein called SPOCD1, which is known to promote the proliferation and/or metastasis of multiple cancers.
The authors suggest that restoring the activity of Rab35 might limit the development of glioblastomas by altering the degradation and recycling of multiple cell surface receptors, including EGFR.
"Rab GTPases are emerging as an important new set of drug targets in cancer," the senior author says. "Our study reveals an unprecedented link between Rab and Arf proteins and identifies new loci for therapeutic intervention in glioblastoma."
https://rupress.org/jcb/article/220/2/e202004229/211682/An-Arf-Rab-cascade-controls-the-growth-and
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fan-arf-rab-cascade&filter=22
Linking endosomal trafficking to aggressive brain cancer
- 1,478 views
- Added
Edited
Latest News
Personalized brain modeling…
By newseditor
Posted 29 Jan
Afternoon chemotherapy impr…
By newseditor
Posted 29 Jan
Propionic acid protects ner…
By newseditor
Posted 28 Jan
How cells prevent harmful e…
By newseditor
Posted 28 Jan
Structured cerebellar conne…
By newseditor
Posted 28 Jan
Other Top Stories
Negative mood linked to prolonged amygdala activity
Read more
How the brain understands sentences
Read more
Does 'harsh parenting' lead to smaller brains?
Read more
Filters from tree branches to purify drinking water
Read more
How teeth sense the cold
Read more
Protocols
Machine learning prediction…
By newseditor
Posted 09 Jan
Differentiating PC12 cells…
By newseditor
Posted 09 Jan
Ultrasensitive sensors reve…
By newseditor
Posted 05 Jan
In vitro-derived medium spi…
By newseditor
Posted 04 Jan
Molecular and spatial signa…
By newseditor
Posted 30 Dec
Publications
HIF-1a accumulation in resp…
By newseditor
Posted 29 Jan
Electrical signals in the E…
By newseditor
Posted 29 Jan
Parathyroid hormone recepto…
By newseditor
Posted 29 Jan
Plasma biomarker profiles i…
By newseditor
Posted 29 Jan
Chemotherapy delivery time…
By newseditor
Posted 29 Jan
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar